Published in Thyroid on December 01, 2004
Lung toxicity in radioiodine therapy of thyroid carcinoma: development of a dose-rate method and dosimetric implications of the 80-mCi rule. J Nucl Med (2006) 1.05
Standard and emerging therapies for metastatic differentiated thyroid cancer. Oncologist (2010) 1.00
Lung dosimetry for radioiodine treatment planning in the case of diffuse lung metastases. J Nucl Med (2006) 1.00
Long-Term Follow-Up of the Therapeutic Outcomes for Papillary Thyroid Carcinoma With Distant Metastasis. Medicine (Baltimore) (2015) 0.88
Histological subtype is the most important determinant of survival in metastatic papillary thyroid cancer. Thyroid Res (2011) 0.87
Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis. J Surg Oncol (2015) 0.85
Assessment of radioiodine therapy efficacy for treatment of differentiated thyroid cancer patients with pulmonary metastasis undetected by chest computed tomography. Oncol Lett (2015) 0.79
Thoracic metastasectomy for thyroid malignancies. Eur J Cardiothorac Surg (2009) 0.78
Clinical significance of diffuse intrathoracic uptake on post-therapy I-131 scans in thyroid cancer patients. Nucl Med Mol Imaging (2013) 0.78
Unusual synchronous skeletal muscle and lung metastasis in papillary thyroid cancer: A case report and review of the literature. Oncol Lett (2014) 0.77
Analysis of radioiodine therapy and prognostic factors of differentiated thyroid cancer patients with pulmonary metastasis: An 8-year retrospective study. Medicine (Baltimore) (2017) 0.75
Massive haemoptysis as an unusual symptom in a patient with papillary thyroid carcinoma. Ther Adv Endocrinol Metab (2013) 0.75
Management of Invasive Differentiated Thyroid Cancer. Thyroid (2016) 0.75
The 1998 enterovirus 71 outbreak in Taiwan: pathogenesis and management. Clin Infect Dis (2002) 1.90
Pathological analysis of congenital cervical cysts in children: 20 years of experience at Chang Gung Memorial Hospital. Chang Gung Med J (2003) 1.61
Well-differentiated thyroid carcinoma with concomitant Hashimoto's thyroiditis present with less aggressive clinical stage and low recurrence. Endocr Pathol (2011) 1.58
Risk stratification of patients with oral cavity squamous cell carcinoma and contralateral neck recurrence following radical surgery. Ann Surg Oncol (2008) 1.58
Genome-wide association study reveals multiple nasopharyngeal carcinoma-associated loci within the HLA region at chromosome 6p21.3. Am J Hum Genet (2009) 1.53
Adriamycin-induced cardiomyocyte and endothelial cell apoptosis: in vitro and in vivo studies. J Mol Cell Cardiol (2002) 1.53
Phyllodes tumor in survivors of childhood osteosarcoma: a single institution's experience. J Pediatr Hematol Oncol (2014) 1.41
Hyperacute rejection from a donor who died of carbamate intoxication--a case report. Am J Emerg Med (2011) 1.39
High incidence of the cardiac variant of Fabry disease revealed by newborn screening in the Taiwan Chinese population. Circ Cardiovasc Genet (2009) 1.39
Activation of DNA methyltransferase 1 by EBV LMP1 Involves c-Jun NH(2)-terminal kinase signaling. Cancer Res (2006) 1.38
Analysis of risk factors of predictive local tumor control in oral cavity cancer. Ann Surg Oncol (2007) 1.37
Leukemia inhibitory factor promotes nasopharyngeal carcinoma progression and radioresistance. J Clin Invest (2013) 1.19
Tumor cell expression of podoplanin correlates with nodal metastasis in esophageal squamous cell carcinoma. Histol Histopathol (2009) 1.15
Tumour inflammasome-derived IL-1β recruits neutrophils and improves local recurrence-free survival in EBV-induced nasopharyngeal carcinoma. EMBO Mol Med (2012) 1.14
Surgical treatment and prognostic analysis for gastrointestinal stromal tumors (GISTs) of the small intestine: before the era of imatinib mesylate. BMC Gastroenterol (2006) 1.14
Adrenal cystic lesions: a clinicopathological analysis of 25 cases with proposed histogenesis and review of the literature. Endocr Pathol (2008) 1.14
Human papillomavirus-16 infection in advanced oral cavity cancer patients is related to an increased risk of distant metastases and poor survival. PLoS One (2012) 1.14
Survival of second and multiple primary tumors in patients with oral cavity squamous cell carcinoma in the betel quid chewing area. Oral Oncol (2006) 1.12
Extrathyroid carcinoma showing thymus-like differentiation (CASTLE) tumor--a new case report and review of literature. Head Neck (2005) 1.11
Novel magnetic/ultrasound focusing system enhances nanoparticle drug delivery for glioma treatment. Neuro Oncol (2010) 1.11
Kinase mutations and imatinib mesylate response for 64 Taiwanese with advanced GIST: preliminary experience from Chang Gung Memorial Hospital. Ann Surg Oncol (2006) 1.11
Retroperitoneal teratomas in infancy and childhood. Pediatr Surg Int (2005) 1.09
Intra-abdominal cystic lymphangiomas in infancy and childhood. Chang Gung Med J (2004) 1.08
Ultrasonography-guided core-needle biopsy of parotid gland masses. AJNR Am J Neuroradiol (2004) 1.08
Thyroid cancer in the thyroid nodules evaluated by ultrasonography and fine-needle aspiration cytology. Thyroid (2005) 1.07
Value of CT in the discrimination of fatal from non-fatal stercoral colitis. Korean J Radiol (2012) 1.06
Necrotic stercoral colitis: importance of computed tomography findings. World J Gastroenterol (2011) 1.06
Congenital mixed malignant germ cell tumor involving cerebrum and orbit. J Perinat Med (2003) 1.06
Resectable gastric cancer: operative mortality and survival analysis. Chang Gung Med J (2002) 1.05
High recurrent rate of multicentric papillary thyroid carcinoma. Ann Surg Oncol (2009) 1.05
Pretreatment primary tumor SUVmax measured by FDG-PET and pathologic tumor depth predict for poor outcomes in patients with oral cavity squamous cell carcinoma and pathologically positive lymph nodes. Int J Radiat Oncol Biol Phys (2008) 1.05
Analysis of risk factors for distant metastases in squamous cell carcinoma of the oral cavity. Cancer (2007) 1.04
Renal metastasis from papillary thyroid microcarcinoma. Acta Otolaryngol (2005) 1.04
Prognostic factors of primary small bowel adenocarcinoma: univariate and multivariate analysis. World J Surg (2006) 1.03
Neck dissection field and lymph node density predict prognosis in patients with oral cavity cancer and pathological node metastases treated with adjuvant therapy. Oral Oncol (2011) 1.03
Surgical management of giant hepatic hemangiomas: complications and review of the literature. Chang Gung Med J (2012) 1.02
Clinical presentations and outcomes of surgical treatment of follicular variant of the papillary thyroid carcinomas. Jpn J Clin Oncol (2006) 1.02
A novel role for TNFAIP2: its correlation with invasion and metastasis in nasopharyngeal carcinoma. Mod Pathol (2010) 1.01
Perforation of the duodenum by an ingested toothbrush. World J Gastroenterol (2008) 1.01
Clinical impact of positive surgical margin status on gastric cancer patients undergoing gastrectomy. Ann Surg Oncol (2009) 1.00
Lipoblastoma/lipoblastomatosis: a clinicopathologic study of 16 cases in Taiwan. Pediatr Surg Int (2005) 0.98
Overexpression of a secretory leukocyte protease inhibitor in human gastric cancer. Int J Cancer (2008) 0.97
Survival in squamous cell carcinoma of the oral cavity: differences between pT4 N0 and other stage IVA categories. Cancer (2007) 0.97
Glutamate receptor, ionotropic, kainate 2 silencing by DNA hypermethylation possesses tumor suppressor function in gastric cancer. Int J Cancer (2010) 0.97
MCP-1 Promoter Polymorphism at 2518 is associated with metastasis of nasopharyngeal carcinoma after treatment. Clin Cancer Res (2007) 0.96
Outcome analysis of patients with well-differentiated oral cavity squamous cell carcinoma. Oral Oncol (2011) 0.96
Peritoneal implanted hepatocellular carcinoma with rupture after TACE presented as acute appendicitis. Hepatogastroenterology (2002) 0.96
Preoperative [18F]fluorodeoxyglucose positron emission tomography standardized uptake value of neck lymph nodes predicts neck cancer control and survival rates in patients with oral cavity squamous cell carcinoma and pathologically positive lymph nodes. Int J Radiat Oncol Biol Phys (2008) 0.96
Ductal adenocarcinoma of the pancreas with huge cystic degeneration: a lesion to be distinguished from pseudocyst and mucinous cystadenocarcinoma. Int J Surg Pathol (2003) 0.96
Heterogeneous ribonucleoprotein k and thymidine phosphorylase are independent prognostic and therapeutic markers for nasopharyngeal carcinoma. Clin Cancer Res (2008) 0.96
Tumor-secreted SDF-1 promotes glioma invasiveness and TAM tropism toward hypoxia in a murine astrocytoma model. Lab Invest (2011) 0.96
Follicular thyroid carcinomas with lung metastases: a 23-year retrospective study. Endocr J (2004) 0.95
An informatics-assisted label-free approach for personalized tissue membrane proteomics: case study on colorectal cancer. Mol Cell Proteomics (2011) 0.94
Incidental and nonincidental papillary thyroid microcarcinoma. Ann Surg Oncol (2008) 0.94
Clinical characteristics of poorly differentiated thyroid carcinomas compared with those of classical papillary thyroid carcinomas. Clin Endocrinol (Oxf) (2007) 0.94
Enhanced interferon signaling pathway in oral cancer revealed by quantitative proteome analysis of microdissected specimens using 16O/18O labeling and integrated two-dimensional LC-ESI-MALDI tandem MS. Mol Cell Proteomics (2009) 0.94
Good tumor control and survivals of squamous cell carcinoma of buccal mucosa treated with radical surgery with or without neck dissection in Taiwan. Oral Oncol (2006) 0.94
Anaerobic thyroid abscess from a thyroid cyst after fine-needle aspiration. Head Neck (2002) 0.93
Local anesthesia with ropivacaine for patients undergoing laparoscopic cholecystectomy. World J Gastroenterol (2009) 0.93
Phosphorylated mTOR expression correlates with poor outcome in early-stage triple negative breast carcinomas. Int J Clin Exp Pathol (2012) 0.92
Surgical outcome of T4a and resected T4b oral cavity cancer. Cancer (2006) 0.92
Vascular endothelial growth factor in thyroid cancers. Cancer Biother Radiopharm (2005) 0.92
Salvage therapy in relapsed squamous cell carcinoma of the oral cavity: how and when? Cancer (2008) 0.92
T4b oral cavity cancer below the mandibular notch is resectable with a favorable outcome. Oral Oncol (2006) 0.91
Papillary thyroid carcinoma with different histological patterns. Chang Gung Med J (2011) 0.91
Treatment of cerebellopontine angle tumors in children: a single institution's experience. J Pediatr Hematol Oncol (2009) 0.91
Comparing late-onset and neonatally-diagnosed congenital cystic adenomatoid malformation of the lung. Chang Gung Med J (2010) 0.90
Diagnosis and therapeutic strategy for papillary thyroid microcarcinoma. Arch Surg (2005) 0.90
Utility of a PI3K/mTOR inhibitor (NVP-BEZ235) for thyroid cancer therapy. PLoS One (2012) 0.90
Preoperative [18F]-fluorodeoxyglucose positron emission tomography standardized uptake value of neck lymph nodes may aid in selecting patients with oral cavity squamous cell carcinoma for salvage therapy after relapse. Eur J Nucl Med Mol Imaging (2009) 0.89
Benefits of palliative surgery for far-advanced gastric cancer. Chang Gung Med J (2002) 0.89
Does adjuvant radiation therapy improve outcomes in pT1-3N0 oral cavity cancer with tumor-free margins and perineural invasion? Int J Radiat Oncol Biol Phys (2008) 0.89
Increasing rates of low-risk human papillomavirus infections in patients with oral cavity squamous cell carcinoma: association with clinical outcomes. J Clin Virol (2013) 0.88
Comparative outcomes in oral cavity cancer with resected pT4a and pT4b. Oral Oncol (2012) 0.88
Long-Term Follow-Up of the Therapeutic Outcomes for Papillary Thyroid Carcinoma With Distant Metastasis. Medicine (Baltimore) (2015) 0.88
Prognostic significance of pituitary tumour-transforming gene-binding factor (PBF) expression in papillary thyroid carcinoma. Clin Endocrinol (Oxf) (2013) 0.88
Tumor stress-induced phosphoprotein1 (STIP1) as a prognostic biomarker in ovarian cancer. PLoS One (2013) 0.87
Identification of a high-risk group among patients with oral cavity squamous cell carcinoma and pT1-2N0 disease. Int J Radiat Oncol Biol Phys (2010) 0.87
Chinese patients with defective IL-12/23-interferon-gamma circuit in Taiwan: partial dominant interferon-gamma receptor 1 mutation presenting as cutaneous granuloma and IL-12 receptor beta1 mutation as pneumatocele. J Clin Immunol (2008) 0.87
False positive F-18 FDG PET/CT in neck and mediastinum lymph nodes due to anthracosis in a buccal cancer patient. Clin Nucl Med (2011) 0.87
High expression of phosphorylated 4E-binding protein 1 is an adverse prognostic factor in esophageal squamous cell carcinoma. Virchows Arch (2010) 0.87
Higher distant failure in young age tongue cancer patients. Oral Oncol (2006) 0.87
PET and PET/CT of the neck lymph nodes improves risk prediction in patients with squamous cell carcinoma of the oral cavity. J Nucl Med (2011) 0.86
Prognostic significance of high podoplanin expression after chemoradiotherapy in esophageal squamous cell carcinoma patients. J Surg Oncol (2011) 0.86
Atrial hemangioma: a rare cause of hydrops fetalis and intrauterine fetal death. Eur J Obstet Gynecol Reprod Biol (2006) 0.86
Tongue and buccal mucosa carcinoma: is there a difference in outcome? Ann Surg Oncol (2010) 0.86
Impact of a second FDG PET scan before adjuvant therapy for the early detection of residual/relapsing tumours in high-risk patients with oral cavity cancer and pathological extracapsular spread. Eur J Nucl Med Mol Imaging (2012) 0.85
Primary intraspinal mesenchymal chondrosarcoma: report of one case. Acta Paediatr Taiwan (2006) 0.85
Role of podoplanin expression in squamous cell carcinoma of upper aerodigestive tract. Histol Histopathol (2013) 0.85
The 30-bp deletion of Epstein-Barr virus latent membrane protein-1 gene has no effect in nasopharyngeal carcinoma. Laryngoscope (2006) 0.85
Cystic change in thyroid cancer. ANZ J Surg (2007) 0.85